Nalaganje...

Are calcineurin inhibitors safer than mTOR inhibitors?

Isakova et al. report that kidney transplant recipients on mammalian target of rapamycin (mTOR) inhibitors do not have a lower risk of allograft failure but do have a higher risk of death than those on calcineurin inhibitors. Careful consideration is, therefore, required before converting to mTOR in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yeh, Heidi, Markmann, James F.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3951270/
https://ncbi.nlm.nih.gov/pubmed/23183834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneph.2012.262
Oznake: Označite
Brez oznak, prvi označite!